المؤلفون: Alvisi P, Arrigo S, Cucchiara S, Lionetti P, Miele E, Romano C, Ravelli A, Knafelz D, Martelossi S, Guariso G, Accomando S, Zuin G, De Giacomo C, Balzani L, Gennari M, Aloi M

المصدر: Biologics: Targets & Therapy, Vol Volume 13, Pp 13-21 (2019)

مصطلحات موضوعية: Pediatric Crohn disease, Infliximab failure, Adalimumab efficacy, Adalimumab safety, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/efficacy-of-adalimumab-as-second-line-therapy-in-a-pediatric-cohort-of-peer-reviewed-article-BTT; https://doaj.org/toc/1177-5491

URL الوصول: https://doaj.org/article/d27e38911dc24dcfb8c6197a436c88cf

المؤلفون: Giovanna Zuin, Erasmo Miele, Marina Aloi, Paolo Lionetti, Claudio Romano, Monia Gennari, Salvatore Accomando, Alberto Ravelli, Stefano Martelossi, Patrizia Alvisi, Costantino De Giacomo, Lucio Balzani, Graziella Guariso, Serena Arrigo, Salvatore Cucchiara, Daniela Knafelz

المساهمون: Alvisi, Patrizia, Arrigo, Serena, Cucchiara, Salvatore, Lionetti, Paolo, Miele, Erasmo, Romano, Claudio, Ravelli, Alberto, Knafelz, Daniela, Martelossi, Stefano, Guariso, Graziella, Accomando, Salvatore, Zuin, Giovanna, De Giacomo, Costantino, Balzani, Lucio, Gennari, Monia, Aloi, Marina, Alvisi P., Arrigo S., Cucchiara S., Lionetti P., Miele E., Romano C., Ravelli A., Knafelz D., Martelossi S., Guariso G., Accomando S., Zuin G., De Giacomo C., Balzani L., Gennari M., Aloi M.

المصدر: Biologics : Targets & Therapy

مصطلحات موضوعية: medicine.medical_specialty, Population, adalimumab efficacy, 03 medical and health sciences, 0302 clinical medicine, adalimumab safety, infliximab failure, pediatric crohn’s disease, Rheumatology, Internal medicine, medicine, Adalimumab, Immunology and Allergy, Targets and Therapy [Biologics], Pharmacology (medical), Adverse effect, education, Pediatric gastroenterology, Original Research, Crohn's disease, education.field_of_study, business.industry, Adalimumab efficacy, Adalimumab safety, Infliximab failure, Pediatric Crohn’s disease, Oncology, Gastroenterology, Hepatology, medicine.disease, Infliximab, 030220 oncology & carcinogenesis, Cohort, pediatric Crohn’s disease, 030211 gastroenterology & hepatology, business, medicine.drug

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae3e036c24e71f4ebeae9b5a49196447
http://europepmc.org/articles/PMC6322517

المؤلفون: Matteo Bramuzzo, Marina Aloi, Simona Gatti, Giulia D'Arcangelo, Dario Dilillo, Francesca Zucconi, Alberto Ravelli, Doriana Lacorte, M.T. Illiceto, Claudio Romano, Serena Arrigo, Salvatore Cucchiara, Daniela Knafelz, Patrizia Alvisi, Giovanna Zuin

المصدر: Journal of Pediatric Gastroenterology & Nutrition. 66:920-925

مصطلحات موضوعية: Male, medicine.medical_specialty, Adolescent, Pediatric ulcerative colitis, mucosal healing, 03 medical and health sciences, 0302 clinical medicine, Gastrointestinal Agents, Internal medicine, infliximab failure, medicine, Adalimumab, Clinical endpoint, Humans, Adalimumab, infliximab failure, mucosal healing, ulcerative colitis, Registries, Child, Adverse effect, ulcerative colitis, Retrospective Studies, business.industry, Gastroenterology, Retrospective cohort study, medicine.disease, Ulcerative colitis, Infliximab, Discontinuation, Treatment Outcome, Child, Preschool, 030220 oncology & carcinogenesis, Pediatrics, Perinatology and Child Health, Colitis, Ulcerative, Female, 030211 gastroenterology & hepatology, Patient Safety, business, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::314f73ef8604dbe6aaa9d37c7201c89d
https://doi.org/10.1097/mpg.0000000000001883

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.